*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C7B1 - Secondary Merkel cell carcinoma - as a primary diagnosis code | C7B1 - Secondary Merkel cell carcinoma - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.48 | |
| Readmission Rate (%) | 26.24 | |
| Unplanned Readmission Rate (%) | 16.05 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 843: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 844: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 2,564 | ||||
| Total Hospitalizations with ICD C7B1 - Secondary Merkel cell carcinoma | 70 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C7B1 - Secondary Merkel cell carcinoma in DRG | 19.39 | ||||
| Avg LOS at DRG | 3.64 | ||||
| Avg LOS with ICD C7B1 - Secondary Merkel cell carcinoma | 2.37 | ||||
| Readmission Rate at DRG | 9.91 | ||||
| Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Unplanned Readmission Rate at DRG | 5.96 | ||||
| Unplanned Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Total Medicare payments at DRG | $27,991,151 | ||||
| Total Medicare payments with ICD C7B1 - Secondary Merkel cell carcinoma | $740,236 | ||||
| Total Medicare payment per Day at DRG | $2,997 | ||||
| Total Medicare payment per Day with ICD C7B1 - Secondary Merkel cell carcinoma | $4,459 | ||||
| Total Medicare payment per Hospitalization at DRG | $10,917 | ||||
| Total Medicare payment per Hospitalization with ICD C7B1 - Secondary Merkel cell carcinoma | $10,575 | ||||
| Total Medicare Charges at DRG | $166,377,625 | ||||
| Total Medicare Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $3,953,888 | ||||
| Avg Charges at DRG | $64,890 | ||||
| Avg Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $56,484 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| SNF Discharge Rate at DRG | 3.12 | ||||
| SNF Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Home Discharge Rate at DRG | 81.08 | ||||
| Home Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | 82.86 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 830: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 826: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 845: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|
| Total Hospitalizations at DRG | 1,334 | ||
| Total Hospitalizations with ICD C7B1 - Secondary Merkel cell carcinoma | 24 | ||
| DRG Share of Total Hospitalizations | 0.0 | ||
| % of Total ICD C7B1 - Secondary Merkel cell carcinoma in DRG | 6.65 | ||
| Avg LOS at DRG | 2.92 | ||
| Avg LOS with ICD C7B1 - Secondary Merkel cell carcinoma | 2.71 | ||
| Readmission Rate at DRG | 12.56 | ||
| Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||
| Unplanned Readmission Rate at DRG | 7.12 | ||
| Unplanned Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||
| Total Medicare payments at DRG | $11,833,763 | ||
| Total Medicare payments with ICD C7B1 - Secondary Merkel cell carcinoma | $221,946 | ||
| Total Medicare payment per Day at DRG | $3,036 | ||
| Total Medicare payment per Day with ICD C7B1 - Secondary Merkel cell carcinoma | $3,415 | ||
| Total Medicare payment per Hospitalization at DRG | $8,871 | ||
| Total Medicare payment per Hospitalization with ICD C7B1 - Secondary Merkel cell carcinoma | $9,248 | ||
| Total Medicare Charges at DRG | $70,506,659 | ||
| Total Medicare Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $1,184,589 | ||
| Avg Charges at DRG | $52,854 | ||
| Avg Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $49,358 | ||
| Mortality Rate at DRG | NA | ||
| Mortality Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||
| SNF Discharge Rate at DRG | 3.75 | ||
| SNF Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||
| Home Discharge Rate at DRG | 79.16 | ||
| Home Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | 83.33 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 16 |
| UNIVERSITY OF MICHIGAN HEALTH SYSTEM | 1500 EAST MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 15 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SCOTT ALAN MCLEAN | 1500 E MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | 11 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SCOTT ALAN MCLEAN | 1500 E MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | 11 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 843: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 844: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 2,564 | ||||
| Total Hospitalizations with ICD C7B1 - Secondary Merkel cell carcinoma | 71 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C7B1 - Secondary Merkel cell carcinoma in DRG | 6.18 | ||||
| Avg LOS at DRG | 3.64 | ||||
| Avg LOS with ICD C7B1 - Secondary Merkel cell carcinoma | 2.35 | ||||
| Readmission Rate at DRG | 9.91 | ||||
| Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Unplanned Readmission Rate at DRG | 5.96 | ||||
| Unplanned Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Total Medicare payments at DRG | $27,991,151 | ||||
| Total Medicare payments with ICD C7B1 - Secondary Merkel cell carcinoma | $748,091 | ||||
| Total Medicare payment per Day at DRG | $2,997 | ||||
| Total Medicare payment per Day with ICD C7B1 - Secondary Merkel cell carcinoma | $4,480 | ||||
| Total Medicare payment per Hospitalization at DRG | $10,917 | ||||
| Total Medicare payment per Hospitalization with ICD C7B1 - Secondary Merkel cell carcinoma | $10,536 | ||||
| Total Medicare Charges at DRG | $166,377,625 | ||||
| Total Medicare Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $3,993,078 | ||||
| Avg Charges at DRG | $64,890 | ||||
| Avg Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $56,241 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| SNF Discharge Rate at DRG | 3.12 | ||||
| SNF Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Home Discharge Rate at DRG | 81.08 | ||||
| Home Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | 83.1 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 581: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 578: SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 830: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 826: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,149 | ||||
| Total Hospitalizations with ICD C7B1 - Secondary Merkel cell carcinoma | 51 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C7B1 - Secondary Merkel cell carcinoma in DRG | 4.44 | ||||
| Avg LOS at DRG | 10.0 | ||||
| Avg LOS with ICD C7B1 - Secondary Merkel cell carcinoma | 6.78 | ||||
| Readmission Rate at DRG | 32.03 | ||||
| Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | 23.4 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Total Medicare payments at DRG | $138,052,599 | ||||
| Total Medicare payments with ICD C7B1 - Secondary Merkel cell carcinoma | $1,080,945 | ||||
| Total Medicare payment per Day at DRG | $2,682 | ||||
| Total Medicare payment per Day with ICD C7B1 - Secondary Merkel cell carcinoma | $3,124 | ||||
| Total Medicare payment per Hospitalization at DRG | $26,812 | ||||
| Total Medicare payment per Hospitalization with ICD C7B1 - Secondary Merkel cell carcinoma | $21,195 | ||||
| Total Medicare Charges at DRG | $653,072,869 | ||||
| Total Medicare Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $3,819,478 | ||||
| Avg Charges at DRG | $126,835 | ||||
| Avg Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $74,892 | ||||
| Mortality Rate at DRG | 5.59 | ||||
| Mortality Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| SNF Discharge Rate at DRG | 12.02 | ||||
| SNF Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Home Discharge Rate at DRG | 49.37 | ||||
| Home Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | 49.02 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 572: SKIN DEBRIDEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 577: SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 160,950 | ||||
| Total Hospitalizations with ICD C7B1 - Secondary Merkel cell carcinoma | 21 | ||||
| DRG Share of Total Hospitalizations | 0.49 | ||||
| % of Total ICD C7B1 - Secondary Merkel cell carcinoma in DRG | 1.83 | ||||
| Avg LOS at DRG | 4.98 | ||||
| Avg LOS with ICD C7B1 - Secondary Merkel cell carcinoma | 4.81 | ||||
| Readmission Rate at DRG | 20.85 | ||||
| Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Unplanned Readmission Rate at DRG | 13.4 | ||||
| Unplanned Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Total Medicare payments at DRG | $1,184,949,733 | ||||
| Total Medicare payments with ICD C7B1 - Secondary Merkel cell carcinoma | $114,412 | ||||
| Total Medicare payment per Day at DRG | $1,477 | ||||
| Total Medicare payment per Day with ICD C7B1 - Secondary Merkel cell carcinoma | $1,133 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,362 | ||||
| Total Medicare payment per Hospitalization with ICD C7B1 - Secondary Merkel cell carcinoma | $5,448 | ||||
| Total Medicare Charges at DRG | $4,222,078,897 | ||||
| Total Medicare Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $700,149 | ||||
| Avg Charges at DRG | $26,232 | ||||
| Avg Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $33,340 | ||||
| Mortality Rate at DRG | 0.67 | ||||
| Mortality Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| SNF Discharge Rate at DRG | 22.29 | ||||
| SNF Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Home Discharge Rate at DRG | 35.46 | ||||
| Home Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 596: MAJOR SKIN DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 580: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 845: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 9,361 | ||||
| Total Hospitalizations with ICD C7B1 - Secondary Merkel cell carcinoma | 16 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C7B1 - Secondary Merkel cell carcinoma in DRG | 1.39 | ||||
| Avg LOS at DRG | 4.43 | ||||
| Avg LOS with ICD C7B1 - Secondary Merkel cell carcinoma | 5.13 | ||||
| Readmission Rate at DRG | 19.61 | ||||
| Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Unplanned Readmission Rate at DRG | 13.62 | ||||
| Unplanned Readmission Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Total Medicare payments at DRG | $61,755,606 | ||||
| Total Medicare payments with ICD C7B1 - Secondary Merkel cell carcinoma | $166,328 | ||||
| Total Medicare payment per Day at DRG | $1,488 | ||||
| Total Medicare payment per Day with ICD C7B1 - Secondary Merkel cell carcinoma | $2,028 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,597 | ||||
| Total Medicare payment per Hospitalization with ICD C7B1 - Secondary Merkel cell carcinoma | $10,396 | ||||
| Total Medicare Charges at DRG | $286,579,798 | ||||
| Total Medicare Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $563,179 | ||||
| Avg Charges at DRG | $30,614 | ||||
| Avg Charges with ICD C7B1 - Secondary Merkel cell carcinoma | $35,199 | ||||
| Mortality Rate at DRG | 0.6 | ||||
| Mortality Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| SNF Discharge Rate at DRG | 18.52 | ||||
| SNF Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA | ||||
| Home Discharge Rate at DRG | 53.82 | ||||
| Home Discharge Rate with ICD C7B1 - Secondary Merkel cell carcinoma | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 39 |
| UNIVERSITY OF MICHIGAN HEALTH SYSTEM | 1500 EAST MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 23 |
| MOFFITT CANCER CENTER | 12902 MAGNOLIA DR | TAMPA | FL | 33612 | 16 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SCOTT ALAN MCLEAN | 1500 E MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | 15 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SCOTT ALAN MCLEAN | 1500 E MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | 15 |